Financial Results at Ipsen | Detailed Financial Performance

Financial Results

Latest Financial Results

Filter

Period

Filter by

recent search

Reset

Showing: 1 – 05 of 29 Financial Results

Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance
 –  27 April 2023

27 April 2023

Download
Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance

Paris (France), 27 April 2023


Ipsen presents strong full-year 2022 results and guidance for 2023
 –  09 February 2023

09 February 2023

Download
Ipsen presents strong full-year 2022 results and guidance for 2023

Paris (France), 9 February 2023


Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance
 –  27 October 2022

27 October 2022

Download
Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance

Paris (France), 27 October 2022


Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
 –  28 July 2022

28 July 2022

Download
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance

Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:


Ipsen delivers a strong sales performance in the first quarter of 2022
 –  27 April 2022

27 April 2022

Download
Ipsen delivers a strong sales performance in the first quarter of 2022

Attachment


Your dedicated contacts